SC
DMAC icon

Steven Cohen’s DiaMedica Therapeutics DMAC Stock Holding History

Steven Cohen’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-552,250
Closed -$5.05M – 1009
2021
Q1 		$5.05M Sell
552,250
-247,750
-31% -$2.31M 0.02% 565
2020
Q4 		$8.11M Hold
800,000
– – 0.04% 488
2020
Q3 		$3.39M Buy
+800,000
New +$4.23M 0.02% 630

Other funds holding DMAC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steven Cohen's DMAC Position: Q2 2021 in Review

Steven Cohen sold out of DiaMedica Therapeutics (DMAC) in Q2 2021, closing a stake of 552,250 shares — an estimated $5.05M sold.

Steven Cohen first reported a position in DMAC in Q3 2020 and held it in 3 quarters. The position peaked at $8.11M in Q4 2020. 43 funds tracked by Wall St. Rank hold DMAC as of Q2 2021.

  • Steven Cohen reported no remaining DiaMedica Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Steven Cohen sold 552,250 DiaMedica Therapeutics shares in Q2 2021, an estimated $5.05M.
  • Steven Cohen first reported a position in DiaMedica Therapeutics in Q3 2020 and held it in 3 quarters.
  • Steven Cohen's DiaMedica Therapeutics position peaked at $8.11M in Q4 2020.
  • 43 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.